mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.002 |
mRNA |
R428 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.002 |
mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.003 |
mRNA |
QL-X-138 |
GDSC1000 |
pan-cancer |
AAC |
-0.099 |
0.003 |
mRNA |
MK 1775 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.003 |
mRNA |
GSK690693 |
GDSC1000 |
pan-cancer |
AAC |
-0.1 |
0.003 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.004 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.004 |
mRNA |
DBeQ |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.004 |
mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.004 |